Rolando M. Viani - Concepedia

Author

Rolando M. Viani

Also Known As

R M Viani, R Viani, R. M. Viani, R.M. Viani, ROLANDO M. VIANI, Roland M Viani, Rolando M Viani, Rolando M. Viani, Rolando Mario Viani, Rolando Viani

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

University of California San Diego Rady Children's Hospital-San Diego AbbVie (United States)University of Alabama at Birmingham University of Colorado Denver

About

Rolando M. Viani is an author at University of California San Diego specializing in medicine, epidemiology, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	398
2	Epidemiology	4	4	101
3	Public Health	3	3	77
4	Family Medicine	1	1	11
5	Hepatology	1	1	24

Rolando M. Viani

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial Hugh Montgomery, Richard Hobbs, Francisco Padilla, The Lancet Respiratory Medicine Covid-19 PandemicAntiviral TherapyPlacebo-controlled TrialMedicineIntramuscular Administration	2022	223
Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study Jürgen K. Rockstroh, Karine Lacombe, Rolando M. Viani, Clinical Infectious Diseases	2018	144
Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial George R. Thompson, Àlex Soriano, Athanasios Skoutelis, Clinical Infectious Diseases	2020	144
Decrease in Hospitalization and Mortality Rates among Children with Perinatally Acquired HIV Type 1 Infection Receiving Highly Active Antiretroviral Therapy Rolando M. Viani, Maria Rosario G. Araneta, Jaime G. Deville, Clinical Infectious Diseases	2004	105
Perinatal HIV Counseling and Rapid Testing in Tijuana, Baja California, Mexico Rolando M. Viani, Maria Rosario G. Araneta, Jorge Ruiz‐Calderon, JAIDS Journal of Acquired Immune Deficiency Syndromes	2005	67
Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-experienced HIV-1 Infected Adolescents Rolando M. Viani, Carmelita Alvero, Terry Fenton, The Pediatric Infectious Disease Journal	2015	63
Pharmacokinetics, Safety, and 48-Week Efficacy of Oral Raltegravir in HIV-1-Infected Children Aged 2 Through 18 Years Sharon Nachman, Naiyu Zheng, Edward P. Acosta, Clinical Infectious Diseases	2013	59
Pharmacokinetics of Antiretroviral Regimens Containing Tenofovir Disoproxil Fumarate and Atazanavir-Ritonavir in Adolescents and Young Adults with Human Immunodeficiency Virus Infection Jennifer J. Kiser, Courtney V. Fletcher, Patricia M. Flynn, Antimicrobial Agents and Chemotherapy	2007	58
Prevalence of Primary HIV‐1 Drug Resistance among Recently Infected Adolescents: A Multicenter Adolescent Medicine Trials Network for HIV/AIDS Interventions Study Rolando M. Viani, Lígia Peralta, Grace M. Aldrovandi, The Journal of Infectious Diseases Primary ImmunodeficiencyHiv Drug ResistanceSexual HealthAdolescent MedicineTreatment And Prevention	2006	54
Gastrostomy Tube Insertion for Improvement of Adherence to Highly Active Antiretroviral Therapy in Pediatric Patients With Human Immunodeficiency Virus Delane Shingadia, Rolando M. Viani, Ram Yogev, PEDIATRICS	2000	47

Page 1